[SCHEDULE 13G/A] Microbot Medical, Inc. SEC Filing

Rhea-AI Filing Summary

Microbot Medical Inc. discloses that three reporting persons — Mitchell P. Kopin, Daniel B. Asher and Intracoastal Capital LLC — may be deemed to beneficially own 4,200,951 shares of common stock, representing 9.99% of the class. That total consists of 7,700 shares held directly by Intracoastal and two warrants exercisable into 2,349,488 and 1,843,763 shares, respectively, which together create the reported position and corresponding shared voting and dispositive power.

The filing also discloses several warrant blocker provisions that exclude additional potential shares from the reported total: certain warrants cannot be exercised to the extent they would push ownership above 9.99% or 4.99%. The filing states that without those blocker provisions the reporting persons could be deemed to beneficially own 7,695,600 shares. The signatories certify the holdings were not acquired to change or influence control of the issuer.

Positive

• Clear disclosure of a near-10% beneficial stake (4,200,951 shares) by named reporting persons
• Breakdown provided showing the position is primarily composed of warrants plus a small number of issued shares (7,700)
• Warrant blocker provisions disclosed, which limit exercise to statutory ownership thresholds and clarify potential dilution

Negative

• Significant potential dilution exists from multiple warrants, although some are excluded by blocker provisions (e.g., 973,139; 207,224; 2,314,286 shares excluded)
• Shared voting/dispositive power over 4,200,951 shares indicates coordinated influence despite the filing being passive
• Theoretical larger ownership (7,695,600 shares) would exist without blocker provisions, illustrating material latent exposure

Insights

Securities Analyst

TL;DR: A passive, near-10% disclosed stake driven largely by warrants with explicit blocker limits.

The Schedule 13G/A reports a combined beneficial position of 4,200,951 shares (9.99%). The position is notable because most of the reported exposure arises from two exercisable warrants rather than fully issued common stock, and multiple warrants include blocker provisions that limit exercise to prevent exceeding 9.99% or 4.99% thresholds. From a market-impact perspective this is material disclosure of concentration but is filed on a passive form, including certification that the holdings are not intended to influence control. Analysts should note the contrast between reported ownership and the larger theoretical ownership (7,695,600 shares) that is constrained by contractual blockers.

Corporate Governance Expert

TL;DR: Shared voting power and warrant mechanics create governance influence potential, though blockers and a passive filing constrain control claims.

The reporting persons disclose shared voting and dispositive power over 4,200,951 shares and explicitly state no intent to change or influence control. The presence of shared power indicates coordinated ownership among the named parties. Important governance details include multiple warrant blocker provisions that legally limit conversion to avoid surpassing ownership thresholds. These contractual limits reduce immediate takeover or control risks, but the underlying warrant economic exposure and the shared voting designation are material facts for shareholders and governance review.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 2)

Microbot Medical Inc.

(Name of Issuer)

Common stock, par value $0.01 per share

(Title of Class of Securities)

59503A204

(CUSIP Number)

06/30/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 59503A204

1

Names of Reporting Persons

Mitchell P. Kopin

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 4,200,951.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 4,200,951.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

4,200,951.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.99 %

12

Type of Reporting Person (See Instructions)

HC, IN

SCHEDULE 13G

CUSIP No. 59503A204

1

Names of Reporting Persons

Daniel B. Asher

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 4,200,951.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 4,200,951.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

4,200,951.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.99 %

12

Type of Reporting Person (See Instructions)

HC, IN

SCHEDULE 13G

CUSIP No. 59503A204

1

Names of Reporting Persons

Intracoastal Capital LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 4,200,951.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 4,200,951.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

4,200,951.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

9.99 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Microbot Medical Inc.
(b)	Address of issuer's principal executive offices: 175 Derby St., Bld. 27, Hingham, MA 02043
Item 2.
(a)	Name of person filing: This Schedule 13G is being filed on behalf of (i) Mitchell P. Kopin, an individual ("Mr. Kopin"), (ii) Daniel B. Asher, an individual ("Mr. Asher") and (iii) Intracoastal Capital LLC, a Delaware limited liability company ("Intracoastal" and together with Mr. Kopin and Mr. Asher, collectively the "Reporting Persons").
(b)	Address or principal business office or, if none, residence: The principal business office of Mr. Kopin and Intracoastal is 245 Palm Trail, Delray Beach, Florida 33483. The principal business office of Mr. Asher is 1011 Lake Street, Suite 311, Oak Park, Illinois 60301.
(c)	Citizenship: Mr. Kopin is a citizen of the United States of America. Mr. Asher is a citizen of the United States of America. Intracoastal is a Delaware limited liability company.
(d)	Title of class of securities: Common stock, par value $0.01 per share
(e)	CUSIP No.: 59503A204
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: As of the close of business on June 30, 2025, each of the Reporting Persons may have been deemed to have beneficial ownership of 4,200,951 shares of Common Stock, which consisted of (i) 7,700 shares of Common Stock held by Intracoastal, (ii) 2,349,488 shares of Common Stock issuable upon exercise of a warrant held by Intracoastal ("Intracoastal Warrant 1") and (ii) 1,843,763 shares of Common Stock issuable upon exercise of a second warrant held by Intracoastal ("Intracoastal Warrant 2"), and all such shares of Common Stock represent beneficial ownership of approximately 9.99% of the Common Stock, based on (1) 36,377,812 shares of Common Stock outstanding as of May 12, 2025, as reported by the Issuer, plus (2) 1,480,504 shares of Common Stock issued by the Issuer since May 13, 2025 (as disclosed on the Form 8-K filed by the Issuer with the Securities and Exchange Commission on June 17, 2025), (3) 2,349,488 shares of Common Stock issuable upon exercise of Intracoastal Warrant 1 and (4) 1,843,763 shares of Common Stock issuable upon exercise of Intracoastal Warrant 2. The foregoing excludes (I) 973,139 shares of Common Stock issuable upon exercise of Intracoastal Warrant 2 because Intracoastal Warrant 2 contains a blocker provision under which the holder thereof does not have the right to exercise Intracoastal Warrant 2 to the extent (but only to the extent) that such exercise would result in beneficial ownership by the holder thereof, together with the holder's affiliates, and any other persons acting as a group together with the holder or any of the holder's affiliates, of more than 9.99% of the Common Stock, (II) 207,224 shares of Common Stock issuable upon exercise of a third warrant held by Intracoastal ("Intracoastal Warrant 3") because Intracoastal Warrant 3 contains a blocker provision under which the holder thereof does not have the right to exercise Intracoastal Warrant 3 to the extent (but only to the extent) that such exercise would result in beneficial ownership by the holder thereof, together with the holder's affiliates, and any other persons acting as a group together with the holder or any of the holder's affiliates, of more than 4.99% of the Common Stock and (III) 2,314,286 shares of Common Stock issuable upon exercise of a fourth warrant held by Intracoastal ("Intracoastal Warrant 4") because Intracoastal Warrant 4 contains a blocker provision under which the holder thereof does not have the right to exercise Intracoastal Warrant 4 to the extent (but only to the extent) that such exercise would result in beneficial ownership by the holder thereof, together with the holder's affiliates, and any other persons acting as a group together with the holder or any of the holder's affiliates, of more than 4.99% of the Common Stock. Without such blocker provisions, each of the Reporting Persons may have been deemed to have beneficial ownership of 7,695,600 shares of Common Stock.
(b)	Percent of class: 9.99%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 0
	(ii) Shared power to vote or to direct the vote: 4,200,951
	(iii) Sole power to dispose or to direct the disposition of: 0
	(iv) Shared power to dispose or to direct the disposition of: 4,200,951
Item 5.	Ownership of 5 Percent or Less of a Class.
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Mitchell P. Kopin

Signature:	/s/ Mitchell P. Kopin
Name/Title:	Mitchell P. Kopin
Date:	08/12/2025

Daniel B. Asher

Signature:	/s/ Daniel B. Asher
Name/Title:	Daniel B. Asher
Date:	08/12/2025

Intracoastal Capital LLC

Signature:	/s/ Mitchell P. Kopin
Name/Title:	Mitchell P. Kopin, Manager
Date:	08/12/2025

FAQ

What stake does the filing say the reporting persons hold in Microbot Medical (MBOT)?

The reporting persons report beneficial ownership of 4,200,951 shares, representing 9.99% of Microbot Medical's common stock.

How is the 4,200,951-share position composed?

The position includes 7,700 issued shares held by Intracoastal and warrants exercisable into 2,349,488 and 1,843,763 shares, respectively, which form the reported total.

Are there restrictions on exercising the warrants?

Yes. Several warrants contain blocker provisions that prevent exercise to the extent doing so would cause beneficial ownership to exceed 9.99% or 4.99%.

Would the reporting persons own more shares absent blocker provisions?

Yes. The filing states that without the blocker provisions the reporting persons may have been deemed to beneficially own 7,695,600 shares.

Does this filing indicate an intent to change control of MBOT?

No. The signatories certify that the securities were not acquired and are not held for the purpose of changing or influencing control of the issuer.